Inventor · disambiguated record
Arnout Gerritsen
Also filed as: GERRITSEN ARNOUT · GERRITSEN ARNOUT F
19 granted patents·4 pending applications·781 citations·filing 2002–2025
95Inventor score
Top patents by PatentIndex Score
23 records- 0198US7247301B2Human monoclonal antibodies to epidermal growth factor receptor (EGFR)GENMAB AS·Filed 2002·Granted Jul 24, 2007·215 cites·24 claims
- 0298US7153507B2Human antibodies specific for interleukin 15 (IL-15)GENMAB AS·Filed 2002·Granted Dec 26, 2006·367 cites·32 claims
- 0395US10344050B2Production of heterodimeric proteinsGENMAB AS·Filed 2012·Granted Jul 9, 2019·40 cites·52 claims
- 0494US7595378B2Human monoclonal antibodies to epidermal growth factor receptor (EGFR)GENMAB AS·Filed 2002·Granted Sep 29, 2009·64 cites·14 claims
- 0593US11492371B2Production of heterodimeric proteinsGENMAB AS·Filed 2019·Granted Nov 8, 2022·9 cites·21 claims
- 0692US10479835B2Agent, uses and methods for treatmentH LUNDBECK AS·Filed 2016·Granted Nov 19, 2019·4 cites·16 claims
- 0792US10428147B2Anti-sortilin antibodies, uses and methods for treatmentH LUNDBECK AS·Filed 2016·Granted Oct 1, 2019·4 cites·7 claims
- 0891US7850962B2Human monoclonal antibodies against CD20GENMAB AS·Filed 2005·Granted Dec 14, 2010·27 cites·49 claims
- 0990US10889650B2Agent, uses and methods for treatmentH LUNDBECK AS·Filed 2019·Granted Jan 12, 2021·2 cites·19 claims
- 1088US11548950B2Agent, uses and methods for treatmentH LUNDBECK AS·Filed 2020·Granted Jan 10, 2023·1 cites·19 claims
- 1185US7329405B2Human antibodies specific for interleukin 15 (IL-15)GENMAB AS·Filed 2003·Granted Feb 12, 2008·11 cites·10 claims
- 1285US7247304B2Methods of treating using anti-IL-15 antibodiesGENMAB AS·Filed 2003·Granted Jul 24, 2007·21 cites·18 claims
- 1384US12331123B2Agent, uses and methods for treatmentH LUNDBECK AS·Filed 2022·Granted Jun 17, 2025·0 cites·22 claims
- 1484US7585961B2Nucleic acid encoding human antibodies specific for interleukin 15 (IL-15)GENMAB AS·Filed 2007·Granted Sep 8, 2009·5 cites·22 claims
- 1582US10894833B2Agents, uses and methods for treatmentH LUNDBECK AS·Filed 2018·Granted Jan 19, 2021·2 cites·4 claims
- 1682US2025277040A1Agent, uses and methods for treatmentH LUNDBECK AS·Filed 2025·Application pending·0 cites
- 1779US8586041B2Human monoclonal antibodies to epidermal growth factor receptor (EGFR)VAN DE WINKEL JAN G J·Filed 2009·Granted Nov 19, 2013·5 cites·23 claims
- 1877US9458236B2Human monoclonal antibodies to epidermal growth factor receptor (EGFR)GENMAB AS·Filed 2013·Granted Oct 4, 2016·2 cites·20 claims
- 1976US12247065B2Method for producing a controlled mixture of two or more different antibodiesGENMAB AS·Filed 2019·Granted Mar 11, 2025·1 cites·36 claims
- 2074US7597892B2Method for treating psoriasis by administering human antibodies specific for Interleukin 15 (IL-15)GENMAB AS·Filed 2007·Granted Oct 6, 2009·1 cites·13 claims
- 2160US2021292414A1Agents, uses and methods for treatmentH LUNDBECK AS·Filed 2020·Application pending·0 cites
- 2247US2007253958A1Human monoclonal antibodies to FC gamma receptor II (CD32)MEDAREX INC·Filed 2007·Application pending·0 cites
- 2346US2010041874A1High throughput methods for characterization of antibodiesGENMAB AS·Filed 2007·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →